LGP — Little Green Pharma Cashflow Statement
0.000.00%
- AU$42.47m
- AU$44.76m
- AU$36.82m
- 60
- 87
- 69
- 82
Annual cashflow statement for Little Green Pharma, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 9 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 24.6 | -18.3 | -9.21 | -8.15 | -4.79 |
| Depreciation | |||||
| Non-Cash Items | -23.6 | 1.01 | 1.29 | 3.44 | 3.98 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.81 | -0.895 | -2.01 | 1.7 | -3.83 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.15 | -17.2 | -6.94 | 0.067 | -0.917 |
| Capital Expenditures | -11.6 | -7.66 | -4.93 | -1.44 | -0.726 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.1 | — | -9.1 | -1.36 | -0.409 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -12.7 | -7.66 | -14 | -2.8 | -1.14 |
| Financing Cash Flow Items | -2.24 | — | -0.838 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 53.9 | 4.73 | 13 | -4.72 | -0.53 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 36 | -20.2 | -7.69 | -7.43 | -2.6 |